Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognition Disorders | 15 | 2018 | 390 | 2.440 |
Why?
|
| Diabetes Mellitus, Type 2 | 23 | 2018 | 1379 | 2.190 |
Why?
|
| Brain | 18 | 2018 | 930 | 2.110 |
Why?
|
| Aging | 8 | 2015 | 881 | 1.580 |
Why?
|
| Cognition | 12 | 2019 | 526 | 1.540 |
Why?
|
| Auditory Perception | 8 | 2009 | 80 | 1.240 |
Why?
|
| Attention | 6 | 2009 | 83 | 1.170 |
Why?
|
| Magnetic Resonance Imaging | 16 | 2018 | 1218 | 1.040 |
Why?
|
| Visual Perception | 7 | 2009 | 112 | 0.900 |
Why?
|
| Caloric Restriction | 2 | 2019 | 92 | 0.810 |
Why?
|
| Neuropsychological Tests | 12 | 2019 | 379 | 0.670 |
Why?
|
| Aged | 29 | 2019 | 9487 | 0.630 |
Why?
|
| Obesity | 3 | 2019 | 1063 | 0.620 |
Why?
|
| Exercise | 2 | 2019 | 591 | 0.610 |
Why?
|
| Exercise Therapy | 1 | 2019 | 229 | 0.590 |
Why?
|
| Female | 34 | 2019 | 18164 | 0.490 |
Why?
|
| Diabetic Retinopathy | 1 | 2014 | 64 | 0.480 |
Why?
|
| Humans | 40 | 2019 | 29093 | 0.480 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2013 | 3 | 0.480 |
Why?
|
| Cerebrovascular Disorders | 1 | 2013 | 48 | 0.460 |
Why?
|
| Pain | 1 | 2015 | 282 | 0.450 |
Why?
|
| Mobility Limitation | 1 | 2014 | 187 | 0.440 |
Why?
|
| Middle Aged | 25 | 2019 | 10829 | 0.440 |
Why?
|
| Male | 30 | 2019 | 17807 | 0.430 |
Why?
|
| Adult | 19 | 2016 | 8420 | 0.420 |
Why?
|
| African Americans | 8 | 2018 | 1373 | 0.410 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2012 | 31 | 0.410 |
Why?
|
| Cerebral Cortex | 2 | 2009 | 141 | 0.390 |
Why?
|
| Coronary Artery Disease | 2 | 2015 | 359 | 0.390 |
Why?
|
| Alzheimer Disease | 1 | 2013 | 312 | 0.360 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2007 | 113 | 0.350 |
Why?
|
| Sensation | 1 | 2009 | 53 | 0.340 |
Why?
|
| Dementia | 3 | 2015 | 234 | 0.330 |
Why?
|
| Acoustic Stimulation | 7 | 2009 | 125 | 0.330 |
Why?
|
| Photic Stimulation | 7 | 2009 | 155 | 0.320 |
Why?
|
| Cues | 4 | 2009 | 67 | 0.320 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2017 | 268 | 0.320 |
Why?
|
| Brain Mapping | 5 | 2014 | 182 | 0.300 |
Why?
|
| Biomedical Research | 1 | 2008 | 153 | 0.300 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2007 | 130 | 0.290 |
Why?
|
| Risk Factors | 8 | 2018 | 3531 | 0.250 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2015 | 182 | 0.250 |
Why?
|
| Cross-Sectional Studies | 6 | 2018 | 1356 | 0.230 |
Why?
|
| Reaction Time | 5 | 2009 | 121 | 0.220 |
Why?
|
| Genome-Wide Association Study | 2 | 2016 | 543 | 0.220 |
Why?
|
| Brain Diseases | 2 | 2014 | 40 | 0.220 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2016 | 1079 | 0.220 |
Why?
|
| Organ Size | 5 | 2018 | 196 | 0.220 |
Why?
|
| European Continental Ancestry Group | 6 | 2018 | 1131 | 0.220 |
Why?
|
| Albuminuria | 4 | 2017 | 176 | 0.210 |
Why?
|
| Aged, 80 and over | 10 | 2016 | 3717 | 0.190 |
Why?
|
| Models, Neurological | 2 | 2014 | 115 | 0.190 |
Why?
|
| Genetic Association Studies | 3 | 2016 | 148 | 0.180 |
Why?
|
| Diabetes Complications | 3 | 2018 | 171 | 0.180 |
Why?
|
| Auditory Cortex | 3 | 2009 | 22 | 0.180 |
Why?
|
| Cohort Studies | 7 | 2018 | 1687 | 0.180 |
Why?
|
| Cardiovascular Diseases | 3 | 2017 | 1013 | 0.180 |
Why?
|
| Analysis of Variance | 3 | 2009 | 454 | 0.180 |
Why?
|
| Blood Glucose | 3 | 2019 | 466 | 0.170 |
Why?
|
| Executive Function | 1 | 2019 | 54 | 0.170 |
Why?
|
| Task Performance and Analysis | 2 | 2009 | 51 | 0.170 |
Why?
|
| Estrogens, Conjugated (USP) | 2 | 2015 | 125 | 0.160 |
Why?
|
| Sex Characteristics | 1 | 2018 | 167 | 0.150 |
Why?
|
| Postmenopause | 2 | 2015 | 397 | 0.140 |
Why?
|
| Young Adult | 3 | 2014 | 2402 | 0.140 |
Why?
|
| Overweight | 1 | 2018 | 256 | 0.140 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 1 | 2016 | 4 | 0.140 |
Why?
|
| Apolipoproteins E | 1 | 2016 | 97 | 0.140 |
Why?
|
| Spectrin | 1 | 2014 | 5 | 0.130 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 12 | 0.130 |
Why?
|
| Vascular Diseases | 1 | 2015 | 61 | 0.130 |
Why?
|
| Prevalence | 2 | 2018 | 896 | 0.130 |
Why?
|
| Arachidonic Acid | 2 | 2011 | 35 | 0.130 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2014 | 53 | 0.130 |
Why?
|
| Glomerular Filtration Rate | 4 | 2017 | 287 | 0.120 |
Why?
|
| Anxiety | 1 | 2015 | 159 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2014 | 836 | 0.120 |
Why?
|
| Cerebrovascular Circulation | 2 | 2015 | 95 | 0.120 |
Why?
|
| Dopamine | 1 | 2016 | 226 | 0.110 |
Why?
|
| Tomography, Spiral Computed | 1 | 2013 | 18 | 0.110 |
Why?
|
| Nerve Net | 1 | 2014 | 115 | 0.110 |
Why?
|
| Diabetic Nephropathies | 1 | 2014 | 195 | 0.110 |
Why?
|
| Depression | 1 | 2015 | 380 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 720 | 0.110 |
Why?
|
| Signal Transduction | 1 | 2016 | 666 | 0.110 |
Why?
|
| Heart Ventricles | 1 | 2013 | 107 | 0.110 |
Why?
|
| Visual Cortex | 2 | 2009 | 33 | 0.110 |
Why?
|
| United States | 6 | 2018 | 3630 | 0.100 |
Why?
|
| Treatment Outcome | 1 | 2019 | 3099 | 0.100 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2011 | 14 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2011 | 35 | 0.100 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2011 | 29 | 0.100 |
Why?
|
| Fatty Acid Desaturases | 1 | 2011 | 44 | 0.100 |
Why?
|
| Proportional Hazards Models | 2 | 2013 | 709 | 0.100 |
Why?
|
| Computational Biology | 1 | 2011 | 86 | 0.100 |
Why?
|
| Prognosis | 1 | 2014 | 1362 | 0.090 |
Why?
|
| Stroke Volume | 1 | 2013 | 278 | 0.090 |
Why?
|
| Science | 1 | 2010 | 8 | 0.090 |
Why?
|
| Ethics, Research | 1 | 2010 | 25 | 0.090 |
Why?
|
| Social Responsibility | 1 | 2010 | 13 | 0.090 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 518 | 0.090 |
Why?
|
| Teaching | 1 | 2010 | 55 | 0.090 |
Why?
|
| Research | 1 | 2010 | 72 | 0.090 |
Why?
|
| Fixation, Ocular | 1 | 2009 | 5 | 0.090 |
Why?
|
| Noise | 1 | 2009 | 6 | 0.090 |
Why?
|
| Space Perception | 1 | 2009 | 26 | 0.090 |
Why?
|
| Perceptual Disorders | 1 | 2009 | 7 | 0.090 |
Why?
|
| Environment | 1 | 2009 | 51 | 0.090 |
Why?
|
| Laboratories | 1 | 2008 | 13 | 0.090 |
Why?
|
| Behavior | 1 | 2008 | 29 | 0.080 |
Why?
|
| Curriculum | 1 | 2010 | 196 | 0.080 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 97 | 0.080 |
Why?
|
| Adolescent | 4 | 2009 | 3254 | 0.080 |
Why?
|
| Sensory Thresholds | 1 | 2007 | 26 | 0.080 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2007 | 5 | 0.080 |
Why?
|
| Echo-Planar Imaging | 1 | 2007 | 16 | 0.080 |
Why?
|
| Mental Processes | 1 | 2007 | 17 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 242 | 0.080 |
Why?
|
| Perception | 1 | 2007 | 92 | 0.070 |
Why?
|
| Age Factors | 1 | 2009 | 1108 | 0.070 |
Why?
|
| Creatinine | 2 | 2017 | 174 | 0.070 |
Why?
|
| Linear Models | 2 | 2017 | 426 | 0.060 |
Why?
|
| Diabetic Angiopathies | 2 | 2015 | 137 | 0.060 |
Why?
|
| Hypertension | 3 | 2017 | 906 | 0.060 |
Why?
|
| Kidney Function Tests | 2 | 2015 | 102 | 0.060 |
Why?
|
| Risk | 2 | 2015 | 289 | 0.060 |
Why?
|
| Genotype | 2 | 2016 | 735 | 0.060 |
Why?
|
| Animals | 1 | 2015 | 7297 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2015 | 464 | 0.060 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 2 | 2011 | 11 | 0.050 |
Why?
|
| Gene Frequency | 2 | 2011 | 225 | 0.050 |
Why?
|
| Fatigue | 1 | 2019 | 68 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 2019 | 138 | 0.040 |
Why?
|
| Exercise Test | 1 | 2019 | 194 | 0.040 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 110 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2019 | 211 | 0.040 |
Why?
|
| Behavior Therapy | 1 | 2018 | 89 | 0.040 |
Why?
|
| Heterozygote | 1 | 2016 | 52 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2017 | 157 | 0.040 |
Why?
|
| Minisatellite Repeats | 1 | 2016 | 8 | 0.040 |
Why?
|
| Life Style | 1 | 2018 | 364 | 0.030 |
Why?
|
| Pedigree | 1 | 2016 | 133 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2019 | 865 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 92 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 637 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2015 | 64 | 0.030 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2015 | 89 | 0.030 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2016 | 96 | 0.030 |
Why?
|
| Stroop Test | 1 | 2014 | 5 | 0.030 |
Why?
|
| Memory | 1 | 2016 | 187 | 0.030 |
Why?
|
| Albumins | 1 | 2014 | 38 | 0.030 |
Why?
|
| Atrophy | 1 | 2014 | 51 | 0.030 |
Why?
|
| Glucose | 1 | 2015 | 163 | 0.030 |
Why?
|
| Estrogens | 1 | 2015 | 162 | 0.030 |
Why?
|
| Smoking | 1 | 2017 | 427 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2014 | 97 | 0.030 |
Why?
|
| Educational Status | 1 | 2014 | 164 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2015 | 859 | 0.030 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2013 | 13 | 0.030 |
Why?
|
| Phenotype | 1 | 2014 | 629 | 0.030 |
Why?
|
| ROC Curve | 1 | 2013 | 149 | 0.030 |
Why?
|
| Incidence | 1 | 2015 | 1119 | 0.030 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2011 | 26 | 0.030 |
Why?
|
| Siblings | 1 | 2011 | 24 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2011 | 24 | 0.030 |
Why?
|
| Multigene Family | 1 | 2011 | 47 | 0.030 |
Why?
|
| Family Health | 1 | 2011 | 78 | 0.020 |
Why?
|
| North Carolina | 1 | 2015 | 1423 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2011 | 192 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 787 | 0.020 |
Why?
|
| Education, Graduate | 1 | 2010 | 3 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 2108 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2008 | 59 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2013 | 562 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2008 | 274 | 0.020 |
Why?
|
| Color Perception | 1 | 2007 | 2 | 0.020 |
Why?
|
| Sample Size | 1 | 2007 | 37 | 0.020 |
Why?
|
| Reference Values | 1 | 2007 | 224 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 103 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2007 | 207 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2007 | 163 | 0.020 |
Why?
|